Results 191 to 200 of about 31,199 (226)
Some of the next articles are maybe not open access.
Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
Immunotherapy, 2013Neovascular age-related macular degeneration (AMD) is the leading cause of legal blindness in patients over the age of 50 in the western world. Intravitreally administered anti-VEGF drugs have been developed to halt neovascular growth in AMD. Randomized trials have demonstrated the excellent safety profile and significant benefit of anti-VEGF therapy ...
David, Xu, Peter K, Kaiser
openaire +2 more sources
Macular atrophy development in neovascular age-related macular degeneration
European Journal of Ophthalmology, 2020Dan Călugăru, Mihai Călugăru
openaire +2 more sources
Coping with Problems Related to Cancer and Cancer Treatment
Ca-A Cancer Journal for Clinicians, 1988exaly +8 more sources
Neovascular Age-Related Macular Degeneration
2006ADAM H. ROGERS, ANDRE WITKIN
openaire +1 more source
Recent progress in the treatment and prevention of cancer‐related lymphedema
Ca-A Cancer Journal for Clinicians, 2015Simona F Shaitelman +2 more
exaly